Changeflow GovPing Pharma & Drug Safety USPTO Patent Granted for Cosmetic Composition w...
Routine Rule Added Final

USPTO Patent Granted for Cosmetic Composition with UV-Filter

Favicon for changeflow.com ChangeBridge: Patent Grants - Pharma (A61K)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted patent US12582591B2 to DSM IP ASSETS B.V. for a cosmetic composition containing a specific ester and a UV-filter. This patent aims to increase the solubilization of the UV-filter, leading to compositions with higher Sun Protection Factor (SPF).

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582591B2, titled 'Increased solubilization of ethylhexyl triazone,' to DSM IP ASSETS B.V. The patent covers a cosmetic composition that includes an ester of a fatty acid and dextrin, a mixture of branched and linear saturated C15-C19 fatty acids, and a specific UV-filter. The primary innovation highlighted is the enhanced solubilization of the UV-filter, which allows for the creation of cosmetic products with a higher Sun Protection Factor (SPF) and greater absorbance of harmful UV light.

This patent grant signifies the USPTO's recognition of novel intellectual property in the cosmetic and pharmaceutical sectors. For companies operating in this space, particularly those involved in the development and manufacturing of sunscreens and other UV-protective cosmetic products, this patent may impact their freedom to operate and product development strategies. While this is a patent grant and not a regulatory rule imposing direct compliance obligations, it establishes exclusive rights for the assignee, potentially requiring licensing or alternative formulation strategies for competitors.

Source document (simplified)

← USPTO Patent Grants

Increased solubilization of ethylhexyl triazone

Grant US12582591B2 Kind: B2 Mar 24, 2026

Assignee

DSM IP ASSETS B.V.

Inventors

Cyrille Deshayes, Christine Mendrok-Edinger

Abstract

The present invention relates to cosmetic composition comprising an ester of a fatty acid and dextrin, a mixture of branched and linear saturated C15-C19, wherein said mixture comprised primarily branched saturated C15-C19, and a UV-filter of the formula (I) This cosmetic composition allows a high amount of the UV-filter of the formula (I) to be solubilized which leads to compositions having a very high absorbance of harmful UV light, i.e. to compositions having a high Sun Protection Factor (SPF).

CPC Classifications

A61Q 17/04 A61Q 19/00 A61K 8/31 A61K 8/06 A61K 8/732 A61K 8/042 A61K 8/37 A61K 8/4966 A61K 2800/20 A61K 2800/49 A61K 2800/74 A61K 8/35 A61K 8/40 A61K 8/73 A61K 2800/40 A61K 8/415 A61K 8/445 A61K 8/891 A61K 2800/592 A61K 8/062 A61K 8/25 A61K 8/41 A61K 8/46 A61K 8/49 A61K 8/4946 A61K 8/496 A61K 8/81 A61K 8/8147 A61K 2800/436 A61K 8/34 A61K 8/345 A61K 8/368 A61K 8/735 A61K 8/965 A61K 2800/591 A61K 8/29 A61K 8/33 A61K 8/361 A61K 8/731 A61K 8/895

Filing Date

2021-12-08

Application No.

18256338

Claims

18

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12582591B2

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Cosmetic Formulation Product Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Product Development
Topics
Cosmetics Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.